HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deepu Madduri Selected Research

idecabtagene vicleucel

12/2021Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy.
1/2021Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma.
1/2019Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Deepu Madduri Research Topics

Disease

29Multiple Myeloma
06/2022 - 11/2017
7COVID-19
01/2022 - 01/2020
6Neoplasms (Cancer)
01/2022 - 01/2019
3Hypoxia (Hypoxemia)
01/2022 - 05/2020
3Inflammation (Inflammations)
01/2022 - 05/2020
3Agammaglobulinemia (Hypogammaglobulinemia)
01/2021 - 01/2020
2Cytokine Release Syndrome
09/2021 - 01/2019
2Infections
09/2021 - 01/2021
2Hypertension (High Blood Pressure)
11/2020 - 06/2020
1Pneumonia (Pneumonitis)
01/2022
1Fatigue
12/2021
1Thrombocytopenia (Thrombopenia)
12/2021
1Parkinsonian Disorders (Parkinsonism)
12/2021
1Movement Disorders (Movement Disorder)
12/2021
1Nausea
12/2021
1Cytopenia
09/2021
1Bites and Stings (Sting)
01/2021
1Frailty
01/2020
1Smoldering Multiple Myeloma
01/2018
1Costello Syndrome
06/2008
1Heart Arrest (Cardiac Arrest)
06/2008

Drug/Important Bio-Agent (IBA)

9Chimeric Antigen ReceptorsIBA
06/2022 - 01/2019
7B-Cell Maturation AntigenIBA
06/2022 - 01/2019
5Pharmaceutical PreparationsIBA
06/2022 - 01/2020
4Proteasome InhibitorsIBA
06/2022 - 01/2020
4selinexorIBA
01/2022 - 01/2020
4Monoclonal AntibodiesIBA
01/2022 - 01/2019
4bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2021 - 01/2019
3idecabtagene vicleucelIBA
12/2021 - 01/2019
3Dexamethasone (Maxidex)FDA LinkGeneric
12/2021 - 01/2020
3daratumumabIBA
01/2021 - 01/2018
3carfilzomibIBA
01/2021 - 01/2020
3CytokinesIBA
10/2020 - 01/2019
3Biomarkers (Surrogate Marker)IBA
10/2020 - 01/2018
2Melphalan (Alkeran)FDA LinkGeneric
11/2020 - 06/2020
2Immunoglobulin G (IgG)IBA
11/2020 - 06/2020
2Interleukin-8 (Interleukin 8)IBA
10/2020 - 05/2020
2Interleukin-6 (Interleukin 6)IBA
10/2020 - 05/2020
2Ferritins (Ferritin)IBA
06/2020 - 01/2020
2fibrin fragment D (D-dimer)IBA
06/2020 - 01/2020
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2022
1InterferonsIBA
01/2022
1gimsilumabIBA
01/2022
17- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA
12/2021
1Bortezomib (Velcade)FDA Link
12/2021
1Bispecific AntibodiesIBA
09/2021
1Intravenous Immunoglobulins (IVIG)FDA Link
01/2021
1Immunoglobulins (Immunoglobulin)IBA
01/2021
1Hyaluronoglucosaminidase (Hyaluronidase)FDA Link
01/2021
1belantamab mafodotinIBA
01/2021
1Single-Domain AntibodiesIBA
01/2021
1insulin receptor-related receptor (IRR)IBA
01/2021
1Immunoconjugates (Immunoconjugate)IBA
01/2021
1isatuximabIBA
01/2021
1InterleukinsIBA
10/2020
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020
1VaccinesIBA
01/2020
1Protein Subunit VaccinesIBA
01/2020
1Immunomodulating AgentsIBA
01/2020
1AntigensIBA
01/2020
1pomalidomideIBA
01/2020
1Proteins (Proteins, Gene)FDA Link
01/2020
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2020
1Anesthetics (Anesthetic Agents)IBA
06/2008

Therapy/Procedure

17Therapeutics
06/2022 - 11/2017
3Immunotherapy
01/2020 - 01/2019
2Artificial Respiration (Mechanical Ventilation)
11/2020 - 06/2020
1Stem Cell Transplantation
10/2020
1Transplantation
01/2018
1Precision Medicine
01/2018
1Anesthesia
06/2008